Trials / Conditions / Amyloid Cardiomyopathy, Transthyretin-Related
Amyloid Cardiomyopathy, Transthyretin-Related
4 registered clinical trials studyying Amyloid Cardiomyopathy, Transthyretin-Related — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM ( NCT07116473 | Eidos Therapeutics, a BridgeBio company | Phase 3 |
| Active Not Recruiting | Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants NCT04988386 | Eidos Therapeutics, a BridgeBio company | Phase 3 |
| Completed | Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations NCT03812172 | Mathew S. Maurer, MD | — |
| Completed | Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10 NCT03294707 | Eidos Therapeutics, a BridgeBio company | Phase 1 |